Massive pleural effusion in a renal transplant recipient on tacrolimus
- PMID: 25249724
- PMCID: PMC4165059
- DOI: 10.4103/0971-4065.133024
Massive pleural effusion in a renal transplant recipient on tacrolimus
Abstract
Fluid and salt retention have been described as a side effect of tacrolimus therapy. We report a case of unexplained massive fluid retention with pleural effusion and ascites in the immediate post-transplant period. The patient recovered immediately on conversion from tacrolimus to sirolimus.
Keywords: Fluid retention; sirolimus; tacrolimus.
Conflict of interest statement
Figures
References
-
- Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs. 1997;54:925–75. - PubMed
-
- BeDell LS, editor. 7th ed. St. Louis, MO: Mosby; 1997. Mosby's Complete Drug Reference Physicians GenRX; pp. 145–8.
-
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft. rejection European FK506 Multicentre Liver Study Group. Lancet. 1994;344:423–8. - PubMed
-
- A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation The U.S. Multicenter FK Liver Study Group. 6 Li The US Multicenter FK506 Liver Study Group. N Engl J Med. 1994;331:1110–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
